Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2018 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2018 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice

  • Authors:
    • Enning Zhang
    • Aiqin Fu
    • Weijun Chen
    • Xiaojie Wang
  • View Affiliations / Copyright

    Affiliations: Medical Oncology, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China, School of Life Science, Ludong University, Yantai, Shandong 264000, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5673-5678
    |
    Published online on: August 30, 2018
       https://doi.org/10.3892/ol.2018.9373
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to discuss the antitumor effect of Tegafur combined with Barbadian on S‑180 tumor‑bearing mice. A murine tumor model was prepared by subcutaneous injection of S‑180 sarcoma cells to the armpit of the right limb of healthy female SPF KM mice. The 24 tumor‑bearing mice were randomly divided into 4 groups: Combination therapy group of Tegafur and Barbadian, Barbadian group, Tegafur group and normal saline control group. Corresponding test substances were given to each group by intragastric administration, respectively, 0.2 ml/mouse, once/day, continuous 5 days, interval for 2 days, recorded as 1 period, 3 periods were continuously performed. Antitumor rate, immune cells, blood biochemistry and inflammatory mediators and other indexes were then respectively measured. Result showed that the antitumor rate for the Combination group was 78%; Barbadian group, 72%; and Tegafur group, ‑89%. White blood cells (WBC) in Barbadian group was significantly higher than that in the control group (P<0.01); lymphocytes (LYMPH), Barbadian group was significantly higher than that in the control group (P<0.01), Tegafur group was significantly lower than the control group (P<0.01); monocytes (MONO), all drug groups were significantly higher than the control group (P<0.01); neutrophils (NEUT), combination group (P<0.01) and Barbadian group (P<0.05) were significantly higher than the control group; blood sugar for the combination (P<0.05) and Barbadian (P<0.01) groups were significantly higher than the control group, while the Tegafur group was significantly lower than the control group (P<0.01). Cholesterol and BUN in the Tegafur group were significantly higher than that in control group (P<0.05). For IL‑1, the combination and Barbadian groups were significantly higher than the control group (P<0.05), while for IL‑6, all the drug groups were significantly higher than the control group (P<0.05). TNF‑α in the Tegafur group was significantly lower than that in the control group (P<0.05). In conclusion, the combination of Tegafur and Barbadian has the significant effect of inhibiting mice S‑180 sarcoma. The single use of chemotherapeutic drug Tegafur has no significant inhibitory effect on mice S‑180 sarcoma. The single use of Barbadian has good antitumor effect and can resist the significant decrease of lymphocytes caused by the chemotherapeutic drug Tegafur. Thus, Barbadian has a good antitumor effect and can protect the immune system of the body, making it a viable treatment option.
View Figures

Figure 1

Figure 2

View References

1 

Liu L, Zheng Y, Zhang Z, Ding C and Lu Z: Clinical observation on oral administration of single drug Tegafur in the treatment of old advanced gastric cancer. Pract J Cancer. 26:294–296. 2011.(In Chinese).

2 

Geng D, Zhang L and Sui M: Study on Barbadian capsules assist advanced tumor chemotherapy. Shanxi Med J. 6:562–564. 2010.(In Chinese).

3 

Xu J: Study on the anti-tumor effect of Barbadian (Huatai TCM). J Shantou Univ Med Coll. 1:25–28. 1994.(In Chinese).

4 

Zhu X and Zhang X: Clinical observation on the prevention and treatment of toxic and side effects of tumor chemotherapy of Barbadian. China's Naturopathy. 5:45–46. 2006.

5 

Zhu K: The inhibition effect of S-1 combined with arctigenin injection on H22 tumor-bearing mice tumor. J Shandong Med Coll. 35:333–335. 2013.(In Chinese).

6 

Qiang G, Na L and Qian Z: Research progress of apoptosis gene in the malignant tumor. J Shanxi Coll Tradit Chin Med. 1:61–62. 2006.

7 

Shuo Z: Experimental study on apoptosis of mice with Xiao Chaihu decoction and 5-fluorouracil-induced Hca-f liver cancer. Liaoning Univ Tradit Chin Med. 2009.

8 

Feng X: Inflammation regulation and sex difference of macrophage phagocytize apoptotic cells of mice. Peking Union Medical College. 2011.

9 

Zhao D, Xie X, Li M and Wang S: Experimental study on the anticancer effect of Curcumine on mice of S180 in vivo. J Xi'an Jiaotong University (Medical Sciences). 1(70–73): 822007.(In Chinese).

10 

Du R, Wang XJ, Xu Q, Ruan X, Liu XS, Qu YQ, Yang LH and Xiao YY: In vivo and in vitro anti-tumor effect of ge-enriched barley seedlings. Food Science. 23:371–374. 2010.(In Chinese).

11 

Zhang Z, Zhao L, Zhang H and Bo L: Influence on the anti-tumor effect before and after the preparation of the Traditional Chinese Medicine rhizoma typhonii in mice. Zhonghua Zhongyiyao Zazhi. 7:1009–1011. 2010.

12 

Liu Q and Meng Q: Discussion on in vivo anti-tumor effect and mechanism of Sargassum hemiphyllum polysaccharides. J First Mil Med Univ. 4:434–436. 2004.

13 

Davis BH and Bigelow NC: Performance evaluation of a hematology blood counter with five-part leukocyte differential capability. Am Clin Lab. 18:8–9. 1999.PubMed/NCBI

14 

Lin Y, Xiao J, He C, Tu H and Wei Y: Expression of IL-1β, IL-6, leptin and the receptors in gastric cancer tissue. J Xi'an Jiaotong Univ (Med Sci).

15 

Tan D, Xu X, Li T, Yi W and Han Z: Study on cell morphology of drought stress-induced programmed cell death of Malus sieversii. Huabei Nongxuebao. 1:50–55. 2007.

16 

Run L, Jing L and Shen X: Experimental study on anti-tumor effect and attenuation of Barbadian. Conference Proceedings of International Biological Medicine and Biotechnology Forum (Hong Kong). 37:40–41. 2006.

17 

Raison CL, Capuron L and Miller AH: Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 27:24–31. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Gatti Lobo L, Tunes Zambaldi M, de Lábio RW, Silva LC, de Arruda Cardoso Smith M and Payão Marques SL: Interleukin-6 polymorphism and Helicobacter pylori infection in Brazilian adult patients with chronic gastritis. Clin Exp Med. 5:112–116. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M and Kunkel SL: Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol. 2:321–326. 1990. View Article : Google Scholar : PubMed/NCBI

20 

North RJ, Dunn PL and Havell EA: A role for tumor necrosis factor in poly(I:C)-induced hemorrhagic necrosis and T-cell-dependent regression of a murine sarcoma. J Interferon Res. 11:333–340. 1991. View Article : Google Scholar : PubMed/NCBI

21 

Coburn JM and Kaplan DL: Engineering biomaterial-drug conjugates for local and sustained chemotherapeutic delivery. Bioconjug Chem. 26:1212–1223. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Shirasaka T and Taguchi T: Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept. Gan To Kagaku Ryoho. 33 Suppl 1:4–18. 2006.(In Japanese). PubMed/NCBI

23 

Wan Y, Hui H, Wang X, Wu J and Sun S: Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer. Zhonghua Zhong Liu Za Zhi. 38:28–34. 2016.(In Chinese). PubMed/NCBI

24 

Hao Z and Xu Z: Effect of sanchinoside on immune function in mice. Chinese Traditional Patent Medicine. 8:31–32. 1986.(In Chinese).

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang E, Fu A, Chen W and Wang X: Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice. Oncol Lett 16: 5673-5678, 2018.
APA
Zhang, E., Fu, A., Chen, W., & Wang, X. (2018). Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice. Oncology Letters, 16, 5673-5678. https://doi.org/10.3892/ol.2018.9373
MLA
Zhang, E., Fu, A., Chen, W., Wang, X."Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice". Oncology Letters 16.5 (2018): 5673-5678.
Chicago
Zhang, E., Fu, A., Chen, W., Wang, X."Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice". Oncology Letters 16, no. 5 (2018): 5673-5678. https://doi.org/10.3892/ol.2018.9373
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang E, Fu A, Chen W and Wang X: Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice. Oncol Lett 16: 5673-5678, 2018.
APA
Zhang, E., Fu, A., Chen, W., & Wang, X. (2018). Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice. Oncology Letters, 16, 5673-5678. https://doi.org/10.3892/ol.2018.9373
MLA
Zhang, E., Fu, A., Chen, W., Wang, X."Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice". Oncology Letters 16.5 (2018): 5673-5678.
Chicago
Zhang, E., Fu, A., Chen, W., Wang, X."Tumor suppression by Tegafur combined with Barbadian in S‑180 tumor‑bearing mice". Oncology Letters 16, no. 5 (2018): 5673-5678. https://doi.org/10.3892/ol.2018.9373
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team